Studies have shown that EOS contributes to the regulation of tumor immune responses by secreting various cytokines and chemokines, such as IL-4, IL-13, and TNF-α, while PLT supports the formation of the tumor microenvironment and tumor angiogenesis by releasing pro-inflammatory cytokines and growth factors. This evidence concerns the gene IL13 and neoplasm.